SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 24, 2019

Cigna Corporation
 (Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation)
001-38769
(Commission File Number)
82-4991898
 (IRS Employer
Identification No.)

900 Cottage Grove Road
Bloomfield, Connecticut 06002
(Address of principal executive offices)  (Zip Code)

Registrant’s telephone number, including area code:

(860) 226-6000

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.01
CI
New York Stock Exchange, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Central Index Key: 0001739940

Item 5.02          Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
 
On September 24, 2019, William D. Zollars informed the Board of Directors of Cigna Corporation (the “Company”) that he will retire from the Board effective November 1, 2019.  Mr. Zollars’ retirement is consistent with the Board’s retirement age policy and aligns with the Board’s ongoing refreshment plans.  Mr. Zollars’ retirement is not the result of any disagreement with the Company.
 


 

 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
Cigna Corporation
     
     
Date:  September 27, 2019
By:
/s/ Nicole S. Jones
   
Nicole S. Jones
   
Executive Vice President and
   
General Counsel

 

 

 
Cigna (NYSE:CI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cigna Charts.
Cigna (NYSE:CI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cigna Charts.